ClinicalTrials.gg
CompletedNCT03254706RCTUpdated Aug 29, 2017

Effect of Increased Improve Time on Adhesive System

An interventional study of Peak etch-and-rinse (P1) and Peak applied for double time(P2X) in Clinical Trial, sponsored by Universidade Estadual de Ponta Grossa. Completed at 1 site in Brazil. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2017-08-29.

Sponsored by Universidade Estadual de Ponta Grossa · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 6 months after the study started (first participant enrolled Feb 2016, registered Aug 2017).
Phase
Not applicable
Study type
Interventional
Enrollment
35
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Objective: This double-blind randomized clinical trial evaluates the influence of increased application time of a new etch-and-rinse two-step adhesive Single Link; (Angelus Dental Products Industry) applied in non-carious cervical lesions (NCCLs).

Methods: A total of 221 restorations were randomly placed in 35 patients assigned in four groups to two different etch-and-rinse two-step adhesive Peak® Universal Bond (P) (Ultradent Products Ind) and Single Link (SL) (Angelus Dental Products Industry). The adhesives systems were applied on the NCCLs follows: P1 - applied according to the manufacturer's; P2X - applied for the double time; SL1 and; SL2X. The resin composite Amelogen (Ultradent) was placed incrementally. The restorations were evaluated imediataly (baseline), 6 and 12 months, using the FDI and USPHS criteria. Statistical analyses were performed using appropriate tests (=0.05).

Read the detailed description

Methods:

Recruitment Patients were recruited as they seek for treatment in the clinics of Dentistry of the local university. No advertisement was made for participant recruitment. Patients were recruited in the order in which they reported for the screening session, thus forming a sample of convenience.

Eligibility criteria A total of 183 participants were examined by two calibrated dental students to check if they met the inclusion and exclusion criteria.

Sample size calculation The annual retention rate to one-step self-etch adhesives in NCCLs was reported to be 4.4% in a recent systematic review. Considering that this decline follow a linear trend, the overall retention rate of one-step self-etch adhesives will be approximately 78% after 5-year of clinical service. With an of 0.05, a power of 80%, and a two-sided test, the minimal sample size will be 41 restorations in each group in order to detect a difference of equivalence of 15% among the test groups.

Interventions A total of 221 restorations were randomly placed in 35 patients assigned in four groups to two different etch-and-rinse two-step adhesive Peak® Universal Bond (P) (Ultradent Products Ind) and Single Link (SL) (Angelus Dental Products Industry).

The adhesives systems were applied on the NCCLs follows: P1 - applied according to the manufacturer's; P2X - applied for the double time; SL1 and; SL2X. The resin composite Amelogen (Ultradent) was placed incrementally. The restorations were evaluated imediataly (baseline), 6 and 12 months, using the FDI and USPHS criteria. Statistical analyses were performed using appropriate tests (=0.05).

02

Conditions studied

  • Clinical Trial

Keywords

  • Dentin adhesive; Non-carious cervical lesions; Longevity.
03

In context

Lead sponsor

Universidade Estadual de Ponta Grossa is the lead sponsor of 8 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

Participants had to be in good general health, at least 18 years old, have an acceptable oral hygiene level, and present at least 20 teeth under occlusion, at least four NCCLs in four different teeth, these lesions had to be non-carious, non-retentive, deeper than 1 mm, and involve both the enamel and dentin of vital teeth without mobility. The cavo-surface margin could not involve more than 50% of enamel, and all lesions had cervical margins ending in dentin.

Exclusion criteria

Exclusion Criteria:

Participants had not be in good general health, at less 18 years old, have not an acceptable oral hygiene level, and present at less 20 teeth under occlusion, at less four NCCLs in four different teeth, these lesions had not be non-carious, retentive and involve only enamel of vital teeth with mobility.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
35 participants (actual)

Study arms

  • Active comparator
    Peak etch-and-rinse (P1)

    Application Mode - According to the manufacturer's instructions.

    Other: Peak etch-and-rinse (P1)

  • Experimental
    Peak applied for double time(P2X)

    Application Mode - According to the manufacturer's instructions, but for the double time.

    Other: Peak applied for double time(P2X)

  • Active comparator
    Single Link etch-and-rinse (SL1)

    Application Mode - According to the manufacturer's instructions.

    Other: Single Link etch-and-rinse (SL1)

  • Experimental
    Single Link double time (SL2X)

    Application Mode - According to the manufacturer's instructions, but for the double time.

    Other: Single Link double time (SL2X)

Interventions

  • OtherPeak etch-and-rinse (P1)

    Application Mode - Peak Adhesive system applied according to the manufacturer's instructions.

    Also known as: P1

  • OtherPeak applied for double time(P2X)

    Application Mode - Peak Adhesive system applied according to the manufacturer's instructions, but for the double time.

    Also known as: P2X

  • OtherSingle Link etch-and-rinse (SL1)

    Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions.

    Also known as: SL1

  • OtherSingle Link double time (SL2X)

    Application Mode - Single Link Adhesive system applied according to the manufacturer's instructions, but for the double time.

    Also known as: SL2X

06

What researchers measure

Primary outcomes

  1. Retention/fracture

    The primary clinical endpoint was restoration retention/fracture

    Time frame: 6 months

Secondary outcomes

  1. Marginal staining

    restoration Marginal staining

    Time frame: 6 months

  2. marginal adaptation

    restoration marginal adaptation

    Time frame: 6 months

  3. postoperative sensitivity

    restoration postoperative sensitivity

    Time frame: 6 months

  4. recurrence of caries.

    restauration recurrence of caries

    Time frame: 6 months

07

Study locations

1 site
  • Universidade Estadual do Oeste do Paraná
    Cascavel, PR 85819-110, Brazil
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 29, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03254706
Lead sponsor
Universidade Estadual de Ponta Grossa
Collaborators
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Responsible party
Eloisa Andrade de Paula (Doctor, Universidade Estadual do Oeste do Paraná) — Principal investigator
First posted
Aug 18, 2017
Start date
Feb 1, 2016
Primary completion
Aug 1, 2017
Completion
Aug 1, 2017
Last update
Aug 29, 2017

Study contacts

Márcio Camargo, Master
study chair · Universidade Estadual do Oeste do Paraná

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion